Beijing Leadman Biochemistry Co Ltd (300289) — Strategic Asset Allocation Index
Beijing Leadman Biochemistry Co Ltd (300289) has a Strategic Asset Allocation Index of 24.5% as of June 2023. Strategic assets (PP&E of CN¥441.15 Million plus long-term investments of CN¥-) total CN¥441.15 Million, measured against net assets of CN¥1.80 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Beijing Leadman Biochemistry Co Ltd Strategic Asset Allocation Index (2008–2021)
This chart shows how Beijing Leadman Biochemistry Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of June 2023, the index stands at 24.5%, representing strategic assets of CN¥441.15 Million against net assets of CN¥1.80 Billion CNY. Explore 300289 cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Beijing Leadman Biochemistry Co Ltd (2008–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Beijing Leadman Biochemistry Co Ltd from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 300289 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 24.0% | CN¥474.96 Million | CN¥474.96 Million | CN¥- | CN¥1.98 Billion | ▼ -17.8 pp |
| 2020 | 41.8% | CN¥575.94 Million | CN¥575.94 Million | CN¥- | CN¥1.38 Billion | ▲ +1.2 pp |
| 2019 | 40.6% | CN¥588.51 Million | CN¥588.51 Million | CN¥- | CN¥1.45 Billion | ▼ -1.5 pp |
| 2018 | 42.1% | CN¥604.80 Million | CN¥604.80 Million | CN¥- | CN¥1.44 Billion | ▼ -1.5 pp |
| 2017 | 43.6% | CN¥620.91 Million | CN¥620.91 Million | CN¥- | CN¥1.43 Billion | ▼ -5.0 pp |
| 2016 | 48.6% | CN¥649.50 Million | CN¥649.50 Million | CN¥- | CN¥1.34 Billion | ▼ -4.8 pp |
| 2015 | 53.4% | CN¥672.96 Million | CN¥672.96 Million | CN¥- | CN¥1.26 Billion | ▼ -9.9 pp |
| 2014 | 63.3% | CN¥692.14 Million | CN¥692.14 Million | CN¥- | CN¥1.09 Billion | ▼ -19.3 pp |
| 2013 | 82.7% | CN¥703.61 Million | CN¥703.61 Million | CN¥- | CN¥851.12 Million | ▲ +13.4 pp |
| 2012 | 69.3% | CN¥527.34 Million | CN¥527.34 Million | CN¥- | CN¥761.02 Million | ▼ -20.2 pp |
| 2011 | 89.5% | CN¥197.56 Million | CN¥197.56 Million | CN¥- | CN¥220.77 Million | ▲ +31.7 pp |
| 2010 | 57.8% | CN¥92.24 Million | CN¥92.24 Million | CN¥- | CN¥159.72 Million | ▲ +15.2 pp |
| 2009 | 42.6% | CN¥44.85 Million | CN¥44.85 Million | CN¥- | CN¥105.32 Million | ▼ -5.0 pp |
| 2008 | 47.6% | CN¥39.93 Million | CN¥39.93 Million | CN¥- | CN¥83.90 Million | — |